Why the study?
The concept, definition, and prognostic value of worsening heart failure are evolving alongside rapid changes in the heart failure treatment landscape and new therapies.
This expert consensus emphasizes the recognition of worsening heart failure as a distinct clinical phase requiring proactive monitoring and rapid optimization of medical therapy to prevent hospitalizations and mortality.
For most patients with chronic heart failure (HF), the clinical course of the disease includes periods of apparent clinical stability punctuated by episodes of clinical deterioration with worsening signs and symptoms, a condition referred to as worsening heart failure (WHF). Over time, episodes of WHF may become more frequent, and patients may enter a cycle of recurrent events associated with deterioration in their quality of life and functional capacity, hospitalizations, and ultimately death. WHF is apparently an old concept but seems to have acquired new boundaries in terms of definition and clinical and prognostic value due to the fast-paced evolution of the HF treatment landscape and the emergence of new drugs in this setting. As a result, the management of WHF is being reshaped. In the present paper, a group of HF experts gathered to discuss the concept, prevention, detection, and treatment of WHF.
No takes yet. Share an insight, caveat, or question.
Cândida et al. (2025) conducted a review in Worsening heart failure. Guideline-directed medical therapy was evaluated. Worsening heart failure marks a high-risk phase in chronic heart failure requiring early detection and prompt optimization of guideline-directed medical therapy to improve patient outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: